Recommendations
| ShowHide Related Items >><< - 02/06/23
- Fortinet announces FortiSP5 ASIC technology
- 01/30/23
- Fortinet expands services, training offerings to further support SOC teams
- 01/12/23
- Fortinet announces participation in AT&T Pebble Beach Pro-Am
- 12/14/22
- Fortinet announces five MSSP partners adopted Fortinet Secure SD-!AN
- 08:40 Today Stifel
- Fortinet price target raised to $72 from $64 at Stifel
- 08:36 Today Roth MKM
- Fortinet price target raised to $70 from $65 at Roth MKM
- 07:50 Today Jefferies
- Fortinet price target raised to $70 from $65 at Jefferies
- 07:38 Today Wedbush
- Fortinet price target raised to $70 from $64 at Wedbush
- 02/07/23
- Fortinet sees FY23 EPS $1.39-$1.41, consensus $1.39
- 02/07/23
- Fortinet sees Q1 EPS 27c-29c, consensus 27c
- 02/07/23
- Fortinet reports Q4 EPS 44c, consensus 39c
- 02/07/23
- Notable companies reporting after market close
- 01/06/23
- White House to unveil cybersecurity strategy, Washington Post reports
- 10/21/22
- Cybereason taps JPMorgan to help find buyer, The Information says
- 02/07/23
- Fly Intel: After-Hours Movers
- 02/07/23
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 01/24/23
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 01/13/23
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 02/07/23
- Fortinet options imply 6.6% move in share price post-earnings
- 01/24/23
- Early notable gainers among liquid option names on January 24th
- 11/16/22
- Fortinet put volume heavy and directionally bearish
- 11/14/22
- Fortinet put volume heavy and directionally bearish
|
Recommendations
| ShowHide Related Items >><< VRTX Vertex Pharmaceuticals - $308.78 /
+3.835 (+1.26%) - 02/07/23
- Vertex Pharmaceuticals board authorizes $3.0B buyback
- 01/11/23
- Vertex Pharmaceuticals expands collaboration with Arbor Biotechnologies
- 12/12/22
- FDA clears Vertex IND application for VX-522 to treat CF
- 12/08/22
- Vertex Pharmaceuticals, Entrada Therapeutics enter EEV therapeutics pact
VRTX Vertex Pharmaceuticals - $308.78 /
+3.835 (+1.26%) - 06:09 Today H.C. Wainwright
- Vertex Pharmaceuticals price target raised to $325 from $300 at H.C. Wainwright
- 05:40 Today Barclays
- Vertex Pharmaceuticals price target raised to $342 from $313 at Barclays
- 01/19/23 Piper Sandler
- Vertex Pharmaceuticals price target raised to $296 from $293 at Piper Sandler
- 01/18/23 Canaccord
- Vertex Pharmaceuticals initiated with a Hold at Canaccord
VRTX Vertex Pharmaceuticals - $308.78 /
+3.835 (+1.26%) - 02/07/23
- Vertex Pharmaceuticals guides FY23 revenue $9.55B-$9.70B, consensus $9.6B
- 02/07/23
- Vertex Pharmaceuticals reports Q4 EPS $3.76, consensus $3.51
- 02/07/23
- Notable companies reporting after market close
- 10/27/22
- Vertex Pharmaceuticals raises 2022 revenue to $8.8B-$8.9B from $8.6B-$8.9B
VRTX Vertex Pharmaceuticals - $308.78 /
+3.835 (+1.26%) - 02/07/23
- Vertex keeps cystic fibrosis drug out of developing countries, NY Times reports
VRTX Vertex Pharmaceuticals - $308.78 /
+3.835 (+1.26%) - 12/30/22
- What You Missed On Wall Street This Morning
- 12/19/22
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 10/31/22
- Biotech Alert: Searches spiking for these stocks today
- 10/27/22
- Fly Intel: After-Hours Movers
VRTX Vertex Pharmaceuticals - $308.78 /
+3.835 (+1.26%) - 02/07/23
- Vertex options imply 3.7% move in share price post-earnings
- 11/28/22
- Early notable gainers among liquid option names on November 28th
- 09/16/22
- Early notable gainers among liquid option names on September 16th
- 09/01/22
- Early notable gainers among liquid option names on September 1st
|
Recommendations
| ShowHide Related Items >><< - $742.31 /
+21.96 (+3.05%) - 02/07/23
- TransDigm says may see 'further upward revision' to FY23 guidance
- 11/14/22
- Lone Pine adds Autodesk stake, reduces Meta Platforms, Microsoft stakes
- 08/12/22
- Soros adds Biohaven, exits Lucid in Q2
- 08/09/22
- TransDigm says 2022 guidance 'remains suspended'
- $742.31 /
+21.96 (+3.05%) - 07:43 Today Credit Suisse
- TransDigm price target raised to $830 from $765 at Credit Suisse
- 07:35 Today Cowen
- TransDigm price target raised to $830 from $695 at Cowen
- 07:28 Today Susquehanna
- TransDigm price target raised to $750 from $665 at Susquehanna
- 07:14 Today Baird
- TransDigm price target raised to $767 from $720 at Baird
- $742.31 /
+21.96 (+3.05%) - 02/07/23
- TransDigm raises FY23 adjusted EPS view to $21.47-$22.87 from $20.68-$22.08
- 02/07/23
- TransDigm reports Q1 adjusted EPS $4.58, consensus $4.25
- 11/10/22
- TransDigm sees FY23 adjusted EPS $20.68-$22.08, consensus $21.18
- 11/10/22
- TransDigm reports Q4 adjusted EPS $5.50, consensus $5.20
|
Recommendations
| ShowHide Related Items >><< - 02/07/23
- Royal Caribbean jumps 5% to $72.54 after reporting Q4 results, FY23 guidance
- 02/07/23
- Royal Caribbean sees FY23 CapEx $4.1B
- 02/07/23
- Royal Caribbean 'very encouraged about the demand environment for 2023'
- 01/12/23
- Royal Caribbean amends, extends revolving credit facilities
- 07:29 Today Susquehanna
- Royal Caribbean price target raised to $85 from $62 at Susquehanna
- 07:07 Today Wells Fargo
- Royal Caribbean price target raised to $78 from $67 at Wells Fargo
- 06:07 Today BofA
- Royal Caribbean upgraded to Neutral from Underperform at BofA
- 05:34 Today Barclays
- Royal Caribbean price target raised to $88 from $74 at Barclays
- 02/07/23
- Royal Caribbean sees FY23 adjusted EPS $3.00-$3.60, consensus $3.25
- 02/07/23
- Royal Caribbean sees Q1 adjusted EPS (85c)-(65c), consensus (80c)
- 02/07/23
- Royal Caribbean reports Q4 adjusted EPS ($1.12), consensus ($1.34)
- 11/03/22
- Royal Caribbean sees Q4 adjusted EPS ($1.50)-($1.30), consensus (67c)
- 08/17/22
- Royal Caribbean seeks approval to sail again in Hong Kong, SCMP reports
- 08/13/22
- Royal Caribbean among companies at risk of liquidity squeeze, Barron's says
- 02/07/23
- What You Missed On Wall Street On Tuesday
- 02/07/23
- What You Missed On Wall Street This Morning
- 01/10/23
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 12/10/22
- Buy/Sell: Wall Street's top 10 stock calls this week
- 02/07/23
- Early notable gainers among liquid option names on February 7th
- 02/07/23
- Unusually active option classes on open February 7th
- 01/19/23
- Royal Caribbean put volume heavy and directionally bearish
- 12/21/22
- Early notable gainers among liquid option names on December 21st
|
Options
| ShowHide Related Items >><< - 02/07/23
- GE Digital signs collaboration agreement with AWS
- 02/06/23
- Thoughtworks acquires Australian AWS consultancy Itoc, terms not disclosed
- 02/06/23
- Air Transport Services backs prior FY22 view, CAM unit completes conversions
- 02/03/23
- 1Life dips after WSJ says FTC considering antitrust suit against Amazon
- 08:32 Today
- Uber expects to generate $1B in ad revenue in 2023
- 08:32 Today
- Uber sees West Coast trips approaching pre-Covid levels
- 08:20 Today
- Uber looking to deliver GAAP operating profit 'at some point this year'
- 08:16 Today
- Uber sees ordering, rides frequency continuing to rise
- 02/07/23
- Bed Bath & Beyond: Default under credit agreement waived
- 02/07/23
- Bed Bath & Beyond has initiated incremental store closures
- 02/07/23
- Bed Bath & Beyond completes public equity offering
- 02/07/23
- Bed Bath & Beyond completes public equity offering, provides strategic update
- 02/06/23
- AMC Entertainment trading resumes
- 02/06/23
- AMC Entertainment trading halted, volatility trading pause
- 02/06/23
- AMC Theatres announces Sightline at AMC ticket pricing initiative
- 01/31/23
- AMC Entertainment to transition role in SCC to pure licensing relationship
- 02/03/23 Truist
- Amazon.com price target lowered to $142 from $160 at Truist
- 02/03/23 Wolfe Research
- Amazon.com price target raised to $130 from $115 at Wolfe Research
- 02/03/23 DA Davidson
- Amazon.com price target raised to $134 from $114 at DA Davidson
- 02/03/23 Evercore ISI
- Amazon price target raised to $160 from $150 at Evercore ISI
- 01/31/23 Mizuho
- Mizuho 'constructive' on Uber shares into Q4 results
- 01/30/23 MoffettNathanson
- Uber initiated with an Outperform at MoffettNathanson
- 01/26/23 Cowen
- Uber price target lowered to $66 from $70 at Cowen
- 01/24/23 KeyBanc
- KeyBanc upgrades Lyft on 'meaningful opportunity' for EBITDA lift
- 07:36 Today Wedbush
- Wedbush keeps Underperform on Bed Bath & Beyond, ups price target to 25c
- 06:08 Today Piper Sandler
- Target price target raised to $220 from $200 at Piper Sandler
- 02/07/23 Odeon Capital
- Bed Bath & Beyond downgraded to Sell from Hold at Odeon Capital
- 02/07/23 Wedbush
- Wedbush cuts Bed Bath & Beyond target to 0c amid last effort to avoid bankruptcy
- 01/30/23 B. Riley
- B. Riley sees APE unit vote opening 'massive' opportunity for AMC
- 01/03/23 B. Riley
- AMC Entertainment price target lowered to $4.50 from $7.50 at B. Riley
- 12/29/22 Wedbush
- AMC Entertainment shares still overpriced, says Wedbush
- 11/25/22 Citi
- AMC Entertainment price target lowered to $1.10 from $1.20 at Citi
- 02/02/23
- Amazon sees Q1 revenue $121B-$126B, consensus $125.11B
- 02/02/23
- Amazon reports Q4 EPS 3c with Rivian loss, consensus 17c
- 02/02/23
- Notable companies reporting after market close
- 10/27/22
- Amazon sees Q4 revenue $140B-$148B, consensus $155.15B
- 06:59 Today
- Uber reports Q4 EPS 29c, consensus (18c)
- 02/07/23
- Notable companies reporting before tomorrow's open
- 02/07/23
- Notable companies reporting before tomorrow's open
- 11/01/22
- Uber reports Q3 EPS (61c), consensus (22c)
- 01/10/23
- Bed Bath & Beyond reports Q3 adjusted EPS ($3.65), consensus ($2.11)
- 01/05/23
- Bed Bath & Beyond sees Q3 net sales of about $1.26B, consensus $1.4B
- 09/29/22
- Bed Bath & Beyond reports Q2 adjusted EPS ($3.22), consensus ($1.85)
- 09/28/22
- Notable companies reporting before tomorrow's open
- 11/08/22
- AMC Entertainment reports Q3 adjusted EPS (20c), consensus (25c)
- 02/06/23
- FTC yields to 'defeat' in antitrust battle with Facebook, Gizmodo reports
- 02/03/23
- 1Life, iRobot deals could be included in Amazon FTC case, Bloomberg says
- 02/03/23
- FTC readying possible antitrust lawsuit against Amazon, WSJ reports
- 02/03/23
- FTC preparing potential antitrust suit against Amazon, WSJ reports
- 01/26/23
- NYC to require Uber and Lyft to be zero emission by 2030, Verge says
- 01/24/23
- Uber Freight laid off 150 workers on Monday, CNBC reports
- 01/19/23
- Uber working to design lower cost EVs customized for ride sharing, WSJ reports
- 01/12/23
- Uber drivers struggle to live off their earnings, NY Times reports
- 02/07/23
- Hudson Bay anchor investor of Bed Bath share sale, Bloomberg reports
- 02/02/23
- Bed Bath & Beyond misses interest payments, weighs Chapter 11, WSJ reports
- 01/31/23
- Bed Bath & Beyond prepares to seek bankruptcy protection, Reuters reports
- 01/29/23
- Bed Bath & Beyond to close 87 more stores, Harmon chain, WSJ reports
- 12/07/22
- AMC Entertainment lenders organized with restructuring advisors, Reorg says
- 11/23/22
- Amazon to invest $1B a year in movies for theatrical release, Bloomberg says
- 08/15/22
- Summer movies show audiences, studio chiefs committed to theaters, WSJ reports
- 08/13/22
- Coinbase looking more like a meme stock, Barron's says
- 02/03/23
- What You Missed On Wall Street On Friday
- 02/03/23
- What You Missed On Wall Street This Morning
- 02/03/23
- Fly Intel: Pre-market Movers
- 02/02/23
- Fly Intel: After-Hours Movers
- 02/04/23
- Buy/Sell: Wall Street's top 10 stock calls this week
- 01/30/23
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 01/19/23
- What You Missed On Wall Street On Thursday
- 01/19/23
- What You Missed On Wall Street This Morning
- 02/07/23
- What You Missed On Wall Street On Tuesday
- 02/07/23
- What You Missed On Wall Street This Morning
- 02/07/23
- Fly Intel: Pre-market Movers
- 02/06/23
- Fly Intel: After-Hours Movers
- 12/28/22
- What You Missed On Wall Street This Morning
- 12/23/22
- Fly Intel: Pre-market Movers
- 12/22/22
- What You Missed On Wall Street On Thursday
- 12/22/22
- What You Missed On Wall Street This Morning
- 02/07/23
- Notable open interest changes for February 7th
- 02/06/23
- Notable open interest changes for February 6th
- 02/03/23
- Notable open interest changes for February 3rd
- 02/02/23
- Amazon options imply 7.0% move in share price post-earnings
- 02/01/23
- Uber call volume above normal and directionally bullish
- 01/26/23
- Uber call volume above normal and directionally bullish
- 01/09/23
- Data confirms customer adding to massive short-term downside hedge in Uber
- 12/22/22
- Uber put volume heavy and directionally bearish
- 07:35 Today
- Unusual call flow in option market yesterday
- 02/07/23
- Notable open interest changes for February 7th
- 02/07/23
- Bed Bath & Beyond call buyer realizes 918% same-day gains
- 02/01/23
- Notable open interest changes for February 1st
- 02/06/23
- Notable open interest changes for February 6th
- 02/03/23
- AMC Entertainment call volume above normal and directionally bullish
- 01/31/23
- Notable open interest changes for January 31st
- 01/30/23
- AMC Entertainment call volume above normal and directionally bullish
|
Recommendations
| ShowHide Related Items >><< - 02/02/23
- Managed care stocks pressured after CMS' preliminary Medicare Advantage rates
- 01/12/23
- California AG files suit against drugmakers, PBMs over insulin prices
- 12/06/22
- Walmart to pay $500,000 over workers' compensation prescription procedures
- 11/07/22
- WBA to invest $3.5B to support VillageMD acquisition of Summit Healt-CityMD
- 02/02/23
- Managed care stocks pressured after CMS' preliminary Medicare Advantage rates
- 01/23/23
- Centene completes divestiture of Magellan Specialty Health to Evolent Health
- 01/03/23
- Centene's Health Net selected for new medi-cal direct contracts
- 12/16/22
- Centene announces $2B increase to stock repurchase program
- 02/06/23 Loop Capital
- Cigna price target lowered to $320 from $350 at Loop Capital
- 01/31/23 JPMorgan
- Medicare Advantage final rule more favorable than feared, says JPMorgan
- 01/03/23 Wells Fargo
- Wells Fargo downgrades Cigna to Equal Weight, lowers price target to $355
- 01/03/23 Wells Fargo
- Cigna downgraded to Equal Weight from Overweight at Wells Fargo
- 07:51 Today Loop Capital
- Centene price target lowered to $95 from $110 at Loop Capital
- 05:26 Today Barclays
- Centene price target lowered to $93 from $100 at Barclays
- 01/31/23 JPMorgan
- Medicare Advantage final rule more favorable than feared, says JPMorgan
- 12/23/22 Wells Fargo
- Humana keeps TRICARE East, Centene loses West region, says Wells Fargo
- 02/03/23
- Cigna sees FY23 adjusted EPS $24.60, consensus $24.84
- 02/03/23
- Cigna reports Q4 adjusted EPS $4.96, consensus $4.86
- 02/02/23
- Notable companies reporting before tomorrow's open
- 02/02/23
- Notable companies reporting before tomorrow's open
- 02/07/23
- Centene backs FY23 adjusted EPS view $6.25-$6.40, consensus $6.36
- 02/07/23
- Centene reports Q4 EPS 86c, consensus 85c
- 02/06/23
- Notable companies reporting before tomorrow's open
- 02/06/23
- Notable companies reporting before tomorrow's open
- 01/27/23
- Cigna sues CVS Health, Amy Bricker for violating noncompete, Bloomberg Law says
- 11/29/22
- Managed care company returns will be tough to keep replicating, WSJ says
- 11/07/22
- Walgreens-backed VillageMD close to $9B deal with Summit, WSJ reports
- 08/18/22
- White House plans for end of COVID-19 vaccine coverage, WSJ reports
- 11/29/22
- Managed care company returns will be tough to keep replicating, WSJ says
- 09/23/22
- Nebraska picks two current, one new Medicaid health plan provider, OWH reports
- 09/23/22
- UnitedHealth, Molina, Centene win Medicaid contracts in Nebraska, Bloomberg says
- 08/18/22
- White House plans for end of COVID-19 vaccine coverage, WSJ reports
- 02/03/23
- What You Missed On Wall Street On Friday
- 02/03/23
- What You Missed On Wall Street This Morning
- 02/03/23
- Fly Intel: Pre-market Movers
- 01/27/23
- What You Missed On Wall Street This Morning
- 01/03/23
- What You Missed On Wall Street On Tuesday
- 01/03/23
- What You Missed On Wall Street This Morning
- 12/16/22
- What You Missed On Wall Street On Friday
- 12/16/22
- What You Missed On Wall Street This Morning
- 01/13/23
- Early notable gainers among liquid option names on January 13th
- 01/17/23
- Centene call volume above normal and directionally bullish
- 01/09/23
- Centene put volume heavy and directionally bearish
- 12/22/22
- Early notable gainers among liquid option names on December 22nd
- 11/21/22
- Centene put volume heavy and directionally bearish
|
Periodicals
|
Top executives at Credit… ShowHide Related Items >><< - 01/24/23
- Barclays appoints new co-heads of Investment Banking
- 12/16/22
- FDIC identifies deficiencies in Credit Suisse, BNP Paribus 2021 plan submissions
- 12/02/22
- Credit Suisse rallies after Chairman says outflows 'basically stopped'
- 11/23/22
- Credit Suisse sees likely loss for Wealth Management in Q4
- 01/27/23 Morgan Stanley
- Credit Suisse resumed with an Equal Weight at Morgan Stanley
- 01/13/23 Barclays
- Credit Suisse price target lowered to CHF 2.90 from CHF 4 at Barclays
- 01/13/23 Deutsche Bank
- Credit Suisse reinstated with a Hold at Deutsche Bank
- 12/20/22 Exane BNP Paribas
- Credit Suisse resumed with an Underperform at Exane BNP Paribas
- 10/27/22
- Credit Suisse reports Q3 net revenue CHF 3.8B vs. CHF 5.43B last year
- 02/07/23
- Apollo in talks to take stake in Credit Suisse investment bank unit, WSJ report
- 02/03/23
- Credit Suisse faces probe after leak of $100B accounts, Bloomberg reports
- 01/23/23
- QIA becomes Credit Suisse's second-biggest shareholder, FT reports
- 01/09/23
- Credit Suisse nears deal to buy Michael Klein's advisory firm, Bloomberg reports
- 02/07/23
- What You Missed On Wall Street On Tuesday
- 02/03/23
- What You Missed On Wall Street This Morning
- 01/13/23
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 01/09/23
- What You Missed On Wall Street On Monday
- 01/26/23
- Unusually active option classes on open January 26th
- 12/15/22
- Largest borrow rate increases among liquid names
- 12/12/22
- Notable open interest changes for December 12th
- 12/02/22
- Unusually active option classes on open December 2nd
|
Initiation
| ShowHide Related Items >><< DAWN Day One Biopharmaceuticals - 01/08/23
- Day One announces top line data from pivotal Phase 2 FIREFLY-1 trial
- 10/17/22
- Day One Biopharmaceuticals announces CRADA with NCI for tovorafenib
- 09/12/22
- Day One Biopharmaceuticals appoints Nicholson as chairman
DAWN Day One Biopharmaceuticals - 02/02/23 Oppenheimer
- Day One Biopharmaceuticals initiated with a Perform at Oppenheimer
- 01/09/23 H.C. Wainwright
- Day One Biopharmaceuticals price target raised to $45 from $35 at H.C. Wainwright
- 01/08/23 Piper Sandler
- Day One Biopharmaceuticals price target raised to $45 from $40 at Piper Sandler
- 12/15/22 H.C. Wainwright
- Day One Biopharmaceuticals initiated with a Buy at H.C. Wainwright
DAWN Day One Biopharmaceuticals - 11/07/22
- Day One Biopharmaceuticals reports Q3 EPS (53c), consensus (53c)
|
Recommendations
| ShowHide Related Items >><< - 12/21/22
- LiveRamp raises share repurchase authorization to $1.1B
- 11/09/22
- LiveRamp rises 19.1%
- 11/09/22
- LiveRamp rises 15.7%
- 11/04/22
- LiveRamp announces 10% workforce reduction, downsizes real estate footprint
- 07:25 Today Susquehanna
- LiveRamp price target raised to $35 from $30 at Susquehanna
- 11/09/22 Craig-Hallum
- LiveRamp price target lowered to $25 from $30 at Craig-Hallum
- 11/09/22 Susquehanna
- LiveRamp price target lowered to $30 from $45 at Susquehanna
- 10/19/22 Morgan Stanley
- LiveRamp price target lowered to $32 from $36 at Morgan Stanley
- 02/07/23
- LiveRamp sees Q4 revenue $147M-$152M, consensus $150.04M
- 02/07/23
- LiveRamp sees FY23 revenue $595M-$600M, consensus $597.69M
- 02/07/23
- LiveRamp reports Q3 adjusted EPS 28c, consensus 27c
- 11/08/22
- LiveRamp sees FY23 revenue $595M-$600M, consensus $592.42M
- 02/07/23
- Fly Intel: After-Hours Movers
- 12/21/22
- Fly Intel: After-Hours Movers
- 11/08/22
- Fly Intel: After-Hours Movers
|
Recommendations
| ShowHide Related Items >><< - 01/10/23
- Kimball Electronics announces CEO Charron to retire, Richard Phillips succeeds
- 05/11/22 Lake Street
- Kimball Electronics initiated with a Buy at Lake Street
- 02/06/23
- Kimball Electronics raises FY23 revenue view to $1.7B-$1.8B from $1.6B-$1.7B
- 02/06/23
- Kimball Electronics reports Q2 adjusted EPS 44c, consensus 52c
- 02/06/23
- Kimball Electronics reports Q2 EPS 43c, consensus 52c
- 11/07/22
- Kimball Electronics backs FY23 revenue view $1.6B-$1.7B, consensus $1.66B
|